Use of a triple helix-forming oligodeoxynucleotides as a novel therapeutic strategy for ERB-B2 positive breast cancer
(Print Material)

Book Cover
Average Rating
Author
Published
, 1998.
Format
Print Material
Status

Description

Loading Description...

Copies

LocationCall NumberStatus
St. Luke’s Radiation Oncology Network DublinPUBLICATIONS ARCHIVE HOLLOn Shelf

More Like This

Loading more titles like this title...

More Details

Published
, 1998.
Language
English

Notes

General Note
Abstract of Poster Presentation. A print copy of this abstract is held in the Oncology Resource Centre.